Accessibility Menu
Baird Medical Investment logo

Baird Medical Investment(NASDAQ) BDMD

Market Cap$46.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-89%
5 YearN/A
1 Year-42%
1 Month-7%
$1.09
-0.91%
-0.01Today
Baird Medical Investment last closing stock price
MetricPriceDate
Last closeUSD 1.102026-08-04
Baird Medical Investment stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.8%USD 1.072026-07-28
1 month-6.78%USD 1.182026-07-02
3 month-38.2%USD 1.782026-05-06
Year to date-19.12%USD 1.362025-12-31
1 year-41.8%USD 1.892025-08-04
Since inception-88.62%USD 9.672021-12-16

Baird Medical Investment Financials at a Glance

Market Cap

$46.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$59.57M

Net Income (TTM)

-$14.82M

EPS (TTM)

-$0.98

P/E Ratio

-1.12

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$1.09

Volume

24,069.359

Open

$1.08

Previous Close

$1.07

Daily Range

$1.06 - $1.12

52-Week Range

$0.76 - $3.75

Estimated Earnings Date

Jul 29, 2026

BDMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Baird Medical Investment

Baird Medical Investment Holdings Limited specializes in engineering and commercializing microwave ablation medical apparatus. The company focuses on minimally invasive treatments for various tumors, including thyroid nodules and hepatic carcinomas, and is headquartered in Guangzhou, China.

Products and Services
  • Microwave ablation devices for tumor treatment
  • Minimally invasive surgical instruments
  • Research and development in medical technology
Growth Outlook
  • Recent quarterly revenue reached $14.58 million, showing potential for growth
  • Gross profit margin improved to 84.7% in Q4 2025
  • Expansion plans in emerging markets could drive future revenue
Financial Highlights
  • Trailing twelve months revenue of $61.5 million, indicating strong sales performance
  • Net income for Q4 2025 was -$15.98 million, reflecting ongoing investment in R&D
  • Current ratio of 1.70 suggests good short-term financial health
Baird Medical Investment Holdings Limited is positioned in the healthcare sector, specifically within medical devices. The company has demonstrated a commitment to innovation, particularly in the field of microwave ablation technology. Recent financial data indicates a significant revenue stream, with a notable gross profit margin, which reflects the efficiency of its operations. Despite reporting a net loss in the latest quarter, the focus on research and development suggests a long-term strategy aimed at enhancing product offerings and market reach. The current ratio indicates that the company is well-equipped to meet its short-term obligations, which is a positive sign for potential investors. Overall, Baird Medical Investment Holdings Limited presents an intriguing opportunity within the medical device industry, particularly for those interested in companies focused on advanced healthcare solutions.
AI Generated • Jul 19, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

146

CEO

Hai Mei Wu

Website

ir.bairdmed.com

Headquarters

Guangzhou, GD 510000, CN

BDMD Financials

Key Financial Metrics (TTM)

Gross Margin

83.79%

Operating Margin

-113.73%

Net Income Margin

-121.04%

Return on Equity

-81.48%

Return on Capital

-50.40%

Return on Assets

-39.14%

Earnings Yield

-89.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$46.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

42.21M

Volume

24.07K

Avg. Volume

110.35K

Financials (TTM)

Gross Profit

$51.54M

Operating Income

-$10.32M

EBITDA

-$7.75M

Operating Cash Flow

-$7.66M

Capital Expenditure

-$2.90M

Free Cash Flow

-$10.55M

Cash & ST Invst.

$178.32K

Total Debt

$19.30M

Baird Medical Investment Performance Analysis

Baird Medical Investment annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 31,457,908N/A
20242024-12-31USD 37,037,10817.7%
20252025-12-31USD 22,537,016-39.2%
Baird Medical Investment sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-34.0%
Q42024-12-3181.9%
Q22025-06-30-66.7%
Q42025-12-3183.1%
Baird Medical Investment annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.02N/A
20232023-12-31USD 0.411801.8%
20242024-12-31USD 0.4917.7%
20252025-12-31USD -0.98N/A
Baird Medical Investment sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-183.7%
Q42024-12-31219.5%
Q22025-06-30-213.2%
Q42025-12-31-27.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$14.58M

-26.8%

Gross Profit

$12.35M

-30.3%

Gross Margin

84.71%

N/A

Market Cap

$46.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$318.01K

N/A

Employees

146

N/A

Net Income

-$15.98M

-294.6%

EBITDA

-$14.55M

-253.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$178.32K

-1.1%

Total Debt

$19.30M

+2304.9%

Accounts Receivable

$42.53M

N/A

Inventory

$1.09M

N/A

Long Term Debt

$6.11M

N/A

Short Term Debt

$13.18M

+1543.0%

Return on Assets

-39.14%

N/A

Return on Invested Capital

-68.65%

N/A

Free Cash Flow

$1.85M

+161.0%

Operating Cash Flow

$1.85M

+211.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FGENFibroGen, Inc.
$9.07-1.63%
OKUROnKure Therapeutics, Inc.
$4.16+1.46%
ECORelectroCore, Inc.
$6.53+4.82%
CTSOCytosorbents Corporation
$0.38+1.93%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$108.27-0.14%
NVDANvidia
$219.22+0.03%
ONDSOndas
$8.87+0.00%
PATHUiPath
$13.82-0.02%

Questions About BDMD

What is the current price of Baird Medical Investment?

Baird Medical Investment is trading at $1.07 per share.

What is the 52-week range for Baird Medical Investment?

Over the past 52 weeks, Baird Medical Investment has traded between $0.76 and $3.75.

How much debt does Baird Medical Investment have?

As of the most recent reporting period, Baird Medical Investment reported total debt of $19.30M.

How much cash does Baird Medical Investment have on hand?

Baird Medical Investment reported $565.82K in cash and cash equivalents in its most recent financial results.

What is Baird Medical Investment’s dividend yield?

Baird Medical Investment does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services